The document summarizes discussions from a conference on emerging health technologies in Spain. It describes the development of early detection systems for new technologies by different Spanish agencies. While systems initially differed, they now work collaboratively. Challenges included improving identification methods and increasing influence. The group now offers a common technology database and continuous evaluation to aid assessment and priority-setting. Future work includes stakeholder engagement, testing methodologies, and evaluating the system's efficiency and impact.

1. Zaragoza, 27-28 April 2017
Are we able to detect new technologies
systematically and timely?
Spanish emerging technologies network.
Methodological advances and work plan.
E. Baños, S. Luengo, A. Llanos, C. Juárez, L Varela, JM. Ruiz-Olano
I. Prieto, T. Molina, I. Gutiérrez-Ibarluzea, G. Benguria-Arrate, J. Asua
AETS, AETSA, AVALIA-T, OSTEBA
PUBLIC HEALTH CONFERENCE
10th anniversary of the Spanish Network of Health Technology Assessment (HTA) Agencies:
Insights for collaborative networking
Towards Patient and public engagement in HTA

2. Agenda
• Where we come from?
• What is our way?
• Changes over time
• What can we offer?
• What do we need from the system and from
our customers?
• Future developments

3. New or emerging health technologies
• Emerging health technology
A health technology that has not yet been adopted
within the healthcare system. Pharmaceuticals are in
the Phase II or III clinical trial, or pre-launch stage;
medical devices are in the pre-marketing stage.
• New health technology
A health technology that is in the launch, early post-
marketing, or early diffusion stages.
Source: https://www.euroscan.org/

4. Introduction of new and emerging health
technologies
Innovation
Development
Security and
efficacy
Technology
analysis
Technology
Assessment
Decision Clinical
Practice
Producers
Buyers
Supliers Health professionals
Professional bodies
Public Health
Politicians Mass-media Pressure groups
(ej. Religion)
Patient organizations
Society
Patients
John Gabbay and Tom Walley
Introducing new health interventions
BMJ, Jan 2006; 332: 64 - 6
Political strategists

5. When to evaluate?….When to inform?….
Experimental Clinical
research
Acceptance
Phase
Accepted and
disseminated
Introduced into the
system
Innovation
Amount of information
Assessment
Variability
Early dialogue
Inform

6. Diffusion control strategies
• Early awareness and alert system
A system that aims to identify, filter and prioritisize
new and emerging health technologies, or new uses
of existing interventions; to assess or predict their
impact on health, health services and/or society; and
to disseminate information.
• Horizon scanning
The systematic identification of health technologies
that are new, emerging or becoming obsolete and
that have the potential to effect health, health
services and/or society.
• Regulation for the introduction
Informative
Normative
• Rational use of the technology

7. IMPACTO DE LOS SISTEMAS DE IDENTIFICACIÓN-EVALUACIÓN DE TECNOLOGÍAS
SANITARIAS NUEVAS Y EMERGENTES EN LA DIFUSIÓN-INTRODUCCIÓN DE DICHAS
TECNOLOGÍAS
Noviembre 2006
• I Gutiérrez-Ibarluzea1, S. Luengo2, R. Villegas3. L. Varela4,
• T. Cerdá4, J Asua1, N Egües-Olazabal1.
• 1 Osteba. Osasun Teknologien Ebaluazioa. Osasun Saila. Eusko Jaurlaritza.
• 2 AETS-Carlos III, Madrid 3 AETSA-Sevilla, Andalucía 4Avalia-T Santiago de Compostela. Galicia.

8. Where we come from?......Opportunity
• Common working time
– Experienced systems
– Incipient systems
– Not regulated established
collaboration
• Coordinated project between
some health technology
assessment agencies of regional
Ministries of Health
“We are what we do, day by
day. So excellence is not an
act, its a habit”.
Aristotle

9. Objectives of the survey 2006
• To know the situation of the identification and evaluation of
new and emerging technologies systems in the NHS
• To evaluate the current impact of its recommendations on the
dissemination of some health technologies
• To establish the basis for a network of information on new
and emerging health technologies in the NHS

10. Methodology (survey 2006)
• Direct contact with the Spanish HTA
organizations that have EWS / questionnaire
description of those systems
• Analysis of its influence on the diffusion

11. Identification-assessment systems in the
National Health System – 2006-
SorTek
Detecta-T
Síntesis
Detecta

12. Conclusions (survey 2006)
• Different systems, methodology and similar action
• 3 EuroScan members (AETS, AETSA and Osteba)
• High degree of agreement on the recommendations issued
• Early Assessment Systems (EAS) modify the diffusion ratios of
the technologies studied in health coverage contexts
• Difficulties in obtaining data
• Impact?
– Higher or lower by the degree of influence of close contexts without
EAS.

13. New challenges…in 2006
• To improve identification methodology
• To be more proactive with experts
• To increase information sources
• Benchmarking
• To increase the number of experts involved
• To expand the survey to other centers with information-
regulation systems in the NHS
• To extend the experience to other communities with HTA
units
• To create an stable network that adequately and timely
reports to the NHS

14. What is our way…?
• To update the GENTecS Group's Early
Detection Strategy for New and
Emerging Health Technologies in
order to adapt it to current needs
• Autonomous entities and the General
Directorate of Basic Service Portfolio
of the MoH and Cohesion Fund of the
Ministry of Health, Social Policies and
Equality, and the Autonomous
Communities, through the
Performance, Insurance and
Financing Commission, under the
Interterritorial Council of the Spanish
NHS.

15. A joint and harmonious work

16. Current actions
• Development of a functional and
operational working model in
collaboration with the Gerneral
directorate of Basic Services Portfolio
of the NHS and Cohesion Fund of the
Ministry of Health, Social Policies and
Equality.
• Translation and adaptation of the
methodological tool created by
EuroScan
• Adaptation of the PriTec prioritization
tool for use in the prioritization of
new and emerging health
technologies.

17. Things that have changed
• Interlocution with the NHS
• Influence on the portfolio of
services
• Presence in different
commissions
• Persistence
• Improvement and
methodological developments
– Search
– Prioritization
– Evaluation
– Format
– GRADE

18. What can we offer?
• A common database of new and
emerging health technologies.
• Facilitate the more efficient and
exhaustive identification of
technologies for the subsequent
prioritization by the corresponding
autonomous systems and by the
Service Portfolio Directorate of the
MoH.
• Staff strategy
• Continuous evaluation and
improvement of the identification-
assessment system.

19. What have we done already?
• We continue working in a
coordinated and joint manner
• We have generated a list of
new and emerging
technologies in 2016 with 63
entries
• Attractive formats for
visualization and prioritization
of the information about
emerging technologies

20. What do we need from our system and from
our customers?
• Who?
• For what?
• What? Needs
• Which one first?
Priorities
• When? Time
• What? Information
• How? Method

21. Future developments
• Stakeholder engagement
• Test different methodologies
in development
– Identification
– Prioritization
– Elaboration of
recommendations
• Evaluate the efficiency of the
system and its impact
• Find new partners and
customers

22. What else..?
Gaizka Benguria Arrate
Osteba,
Basque Office for Health Technology
Assessment
Basque Health Department
Alda Rekalde 39A - Bilbao
g-benguria@euskadi.eus
http://www.osakidetza.euskadi.eus/osteba
https://www.facebook.com/pages/Osteba/3
65563420144977